Renal vein thrombosis and membranous glomerulopathy in a patient homozygote for factor V Leiden mutation:A mere coincidence?

Eran Elinav; Dvora Rubinger; Nurith Hiller; Galina Pizov; Eyal Nadir; Yami Shapira; Samuel N. Heyman

doi:10.1160/TH05-08-0565

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2006; 95(04): 740-743
DOI: 10.1160/TH05-08-0565

Case Report

Schattauer GmbH

Renal vein thrombosis and membranous glomerulopathy in a patient homozygote for factor V Leiden mutation:A mere coincidence?

Authors

Eran Elinav

¹Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Mount Scopus Campus
Dvora Rubinger

²Nephrology Department, Hadassah-Hebrew University Medical Center, Ein-Kerem Campus
Nurith Hiller

³Radiology Department, Hadassah-Hebrew University Medical Center, Mount Scopus Campus
Galina Pizov

⁴Pathology Department, Hadassah-Hebrew University Medical Center, Mount Scopus Campus; Jerusalem, Israel
Eyal Nadir

¹Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Mount Scopus Campus
Yami Shapira

¹Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Mount Scopus Campus
Samuel N. Heyman

¹Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Mount Scopus Campus

Abstract

Full Text

References

References
1 Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 2003; 23: 324-32.
2 Dizon-Townson DS, Nelson LM, Jang H. et al. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. AmJ Obstet Gynecol 1997; 176: 883-6.
3 Juul K, Tybjaerg-Hansen A, Steffensen R. et al. FactorV Leiden: The Copenhagen City Heart Study and 2 meta-analyses. Blood 2002; 100: 3-10.
4 Heit JA, Sobell JL, Li H. et al. The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study. J Thromb Haemost 2005; 03: 305-11.
5 Nickolas TL, Radhakrishnan J, Appel GB. Hyperlipidemia and thrombotic complications in patients with membranous nephropathy. Semin Nephrol 2003; 23: 406-11.
6 Rabelink TJ, Zwaginga JJ, Koomans HA. et al. Thrombosis and hemostasis in renal disease. Kidney Int 1994; 46: 287-96.
7 Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 1985; 28: 429-39.
8 Wagoner RD, Stanson AW, Holley KE. et al. Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Kidney Int 1983; 23: 368-74.
9 Pasquariello A, Camerini E. Unilateral renal vein thrombosis and pulmonary embolism complicating membranous nephropathy. AmJ Nephrol 1992; 12: 134-6.
10 Alkjaersig N, Fletcher AP. Narayanan, et al. Course and resolution of the coagulopathy in nephrotic children. Kidney Int 1987; 31: 772-80.
11 Robert A, Olmer M, Sampol J. et al. Clinical correlation between hypercoagulability and thromboembolic phenomena. Kidney Int 1987; 31: 830-5.
12 Morrissey EC, McDonald BR, Rabetoy GM. Resolution of proteinuria secondary to bilateral renal vein thrombosis after treatment with systemic thrombolytic therapy. Am J Kidney Dis 1997; 29: 615-9.
13 Ozawa T, Boedecker EA, Schorr W. et al. Immunecomplex disease with unilateral renal vein thrombosis. Arch Pathol Lab Med 1976; 100: 279-82.